Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate ENPP1 Expression and Its Role in Immune Evasion and Chemoresistance in Bladder Cancer

NCT06657755 is registered in ClinicalTrials.gov with Lanzhou University Second Hospital as lead sponsor.

NCT NCT06657755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate ENPP1 Expression and Its Role in Immune Evasion and Chemoresistance in Bladder Cancer
Lead sponsor
Lanzhou University Second Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
October 20, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder (urothelial, transitional cell) cancer